Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Elicio Therapeutics, Inc. (ELTX) Gross Margin data is not available for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-39.57M |
|
-- |
|
-- |
|
$37.71M |
|
$-37.71M |
|
$-1.86M |
|
$-39.57M |
|
$-39.57M |
|
$-39.57M |
|
$-39.57M |
|
$-39.57M |
|
$-39.57M |
|
$-37.71M |
|
$-36.37M |
|
15.31M |
|
15.31M |
|
$-2.58 |
|
$-2.58 |
|
| Balance Sheet Financials | |
$19.31M |
|
$0.29M |
|
$6.55M |
|
$25.86M |
|
$8.11M |
|
$9.41M |
|
$16.12M |
|
$24.23M |
|
$1.64M |
|
$1.64M |
|
$1.64M |
|
17.80M |
|
| Cash Flow Statement Financials | |
$-36.95M |
|
$-0.02M |
|
$36.70M |
|
$19.49M |
|
$19.27M |
|
$-0.23M |
|
$2.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.85 |
|
5.75 |
|
|
Gross Margin |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2418.77% |
|
-2418.77% |
|
-153.01% |
|
-358.34% |
|
$0.09 |
|
$-2.41 |
|
$-2.41 |
|